Newsletter Subject

Could this Healthcare Stock really climb 101.14% by 2024?

From

markettickerpress.com

Email Address

editor@markettickerpress.com

Sent On

Fri, Oct 27, 2023 01:18 PM

Email Preheader Text

Earnings Alert. If you cannot see this email properly, please click --------------------------------

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"]( The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. [Get the name of the stock here ]( --------------------------------------------------------------- October 27, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Is This "Royalty Strategy" the Most Overlooked Way to Play Gold?]( are catching on to a little-known strategy that has been quietly funding gold miners... This "royalty strategy" offers investors certain advantages over other gold vehicles, such as bullion, ETFs, and stocks. It provides investors exposure to rising gold prices and mining success - without all the operational risks and costs. [Read this startling report on a huge untapped opportunity]( --------------------------------------------------------------- [ON Semiconductor]( Symbol: [ON]( Recent Price: $82.79 Average Analyst Price Target: $118.75 (40.97%) Market Cap: $35.02B Last Year's EPS: $1.19 Consensus EPS Forecast: $1.21 Expected Earnings Date: Oct 30 2023 Recent Analyst Action: Anthony Stoss, analyst at Craig-Hallum, reiterates coverage on [ON Semiconductor (ON)]( in the Technology sector with a Buy rating and a price target of n/a (23 hours ago). [TipRanks.com]( also reports that [ON Semiconductor]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $118.75 . The target pricing ranges from a high forecast of $135 down to a low forecast of $100. [ON Semiconductor (ON)](’s last closing price was $82.79 which would put the average price target at 40.97% upside. Here are 3rd party ratings for [ON](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Buy, Bottom 39% (152 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [AI to Disrupt Energy Market (Huge Potential Gains!)]( orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… It makes them all look like small fries… In fact, just one year of this untapped resource in the USA alone provides 5X as much power as the largest oil field on Earth… And this resource is about to be unleashed on the world like never before with the help of one tiny Silicon Valley company…[Click here for all the details…]( --------------------------------------------------------------- [ZoomInfo Technologies]( Symbol: [ZI]( Recent Price: $15.51 Average Analyst Price Target: $22.50 (59.38%) Market Cap: $6.31B Last Year's EPS: $0.24 Consensus EPS Forecast: $0.23 Expected Earnings Date: Oct 30 2023 Recent Analyst Action: Brent Bracelin, analyst at Piper Sandler, reiterates coverage on [ZoomInfo Technologies (ZI)]( in the Technology sector with a Buy rating and a price target of $21 (3 days ago). [TipRanks.com]( also reports that [ZoomInfo Technologies]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $22.50 . The target pricing ranges from a high forecast of $25 down to a low forecast of $21. [ZoomInfo Technologies (ZI)](’s last closing price was $15.51 which would put the average price target at 59.38% upside. Here are 3rd party ratings for [ZI](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 20% (50 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Tenet Healthcare]( Symbol: [THC]( Recent Price: $53.41 Average Analyst Price Target: $91.80 (74.52%) Market Cap: $5.47B Last Year's EPS: $1.42 Consensus EPS Forecast: $1.25 Expected Earnings Date: Oct 30 2023 Recent Analyst Action: Jason Cassorla, analyst at Citi, reiterates coverage on [Tenet Healthcare (THC)]( in the Healthcare sector with a Buy rating and a price target of $90 (3 days ago). [TipRanks.com]( also reports that [Tenet Healthcare]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $91.80 . The target pricing ranges from a high forecast of $98 down to a low forecast of $105. [Tenet Healthcare (THC)](’s last closing price was $53.41 which would put the average price target at 74.52% upside. Here are 3rd party ratings for [THC](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 39% (98 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Hidden $5 Stock Holds Tech World Hostage]( monsters like Apple, Amazon, Microsoft and many more can no longer avoid doing business with [this one company that trades for only $3](... All of them are held hostage by the CEO's brilliant business tactics. And what's even crazier... Is that his tactics reach all the way to the public. He intentionally set up his company's stock under a [secret trade name.](.. Did he fool you too? [Click here to see more.]( --------------------------------------------------------------- [JinkoSolar]( Symbol: [JKS]( Recent Price: $26.32 Average Analyst Price Target: $45.46 (97.53%) Market Cap: $1.32B Last Year's EPS: $1.53 Consensus EPS Forecast: $2.08 Expected Earnings Date: Oct 30 2023 Recent Analyst Action: Philip Shen, analyst at Roth MKM, reiterates coverage on [JinkoSolar (JKS)]( in the Energy sector with a Buy rating and a price target of $70 (2 months ago). [TipRanks.com]( also reports that [JinkoSolar]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $45.46 . The target pricing ranges from a high forecast of $70 down to a low forecast of $19.32. [JinkoSolar (JKS)](’s last closing price was $26.32 which would put the average price target at 97.53% upside. Here are 3rd party ratings for [JKS](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 30% (175 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Pacific Biosciences]( Symbol: [PACB]( Recent Price: $7.15 Average Analyst Price Target: $11.20 (75.66%) Market Cap: $1.68B Last Year's EPS: -$0.31 Consensus EPS Forecast: -$0.34 Expected Earnings Date: Oct 30 2023 Recent Analyst Action: Tejas Savant, analyst at Morgan Stanley, reiterates coverage on [Pacific Biosciences (PACB)]( in the Technology sector with a Hold rating and a price target of $10 (2 days ago). [TipRanks.com]( also reports that [Pacific Biosciences]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $11.20 . The target pricing ranges from a high forecast of $9 down to a low forecast of $10. [Pacific Biosciences (PACB)](’s last closing price was $7.15 which would put the average price target at 75.66% upside. Here are 3rd party ratings for [PACB](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 39% (98 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Disturbing Truth About Biden's New Program To Seize Your Cash]( s disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now. [Get The Rest Of The Details Here]( --------------------------------------------------------------- [MiMedx Group]( Symbol: [MDXG]( Recent Price: $6.13 Average Analyst Price Target: $12.50 (101.14%) Market Cap: $703.62M Last Year's EPS: -$0.06 Consensus EPS Forecast: $0.005 Expected Earnings Date: Oct 30 2023 Recent Analyst Action: Anthony Petrone, analyst at Mizuho Securities, reiterates coverage on [MiMedx Group (MDXG)]( in the Healthcare sector with a Buy rating and a price target of $14 (2 months ago). [TipRanks.com]( also reports that [MiMedx Group]( currently has 2 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $12.50 . The target pricing ranges from a high forecast of $14 down to a low forecast of $11. [MiMedx Group (MDXG)](’s last closing price was $6.13 which would put the average price target at 101.14% upside. Here are 3rd party ratings for [MDXG](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [CarParts.com Inc]( Symbol: [PRTS]( Recent Price: $3.35 Average Analyst Price Target: $9.83 (209.85%) Market Cap: $192.72M Last Year's EPS: $0.02 Consensus EPS Forecast: -$0.001 Expected Earnings Date: Oct 30 2023 Recent Analyst Action: Ryan Sigdahl, analyst at Craig-Hallum, reiterates coverage on [CarParts.com Inc (PRTS)]( in the Consumer Cyclical sector with a Buy rating (2 months ago). [TipRanks.com]( also reports that [CarParts.com Inc]( currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $9.83 . The target pricing ranges from a high forecast of $7 down to a low forecast of $17. [CarParts.com Inc (PRTS)](’s last closing price was $3.35 which would put the average price target at 209.85% upside. Here are 3rd party ratings for [PRTS](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 36% (160 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Buy this AI Stock Before Elon's Announcement]( Tiwari, the man who picked Nvidia before it skyrocketed as high as 5,246%, is now recommending [this AI stock…]( Because it’s most likely supplying Elon Musk with a key piece of advanced tech for his new AI venture. Hurry… Elon Musk has promised that he “will share more information [about this AI project] over the next couple of weeks.” If he mentions the name of this supplier in a tweet or during a press conference, there’s no telling how high shares could go. [Click here now before it’s too late.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. [If you are not a human, click here.]( MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software

Marketing emails from markettickerpress.com

View More
Sent On

04/03/2024

Sent On

03/03/2024

Sent On

03/03/2024

Sent On

03/03/2024

Sent On

02/03/2024

Sent On

02/03/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.